Page 16 - Export-Marketing-6

developing countries (nearly 85% of the
world population) only consume 21% of
the produced medicines.
However, it seems that nowadays this
trend is going to change due to different
causes like the economic decline of
western countries as well as the emergence
of new economies in the world. In other
words, the pharmaceutical industry is
shifting from the US and Europe toward
emerging markets in Asia and Africa.
It is said that a remarkable volume of
the growth in the global pharmaceutical
market in the coming years will be affected
by the growth in the emerging markets
like Brazil, Russia, India, China, Ukraine,
Poland, Argentina, Egypt, Indonesia,
Algeria, South Africa, Romania, and
Vietnam.
The growth in the emerging markets is
affected by the growth in the population,
more access to medicines and new health
services as well as the economic plans of
governments.
According to the definitions of the World
Health Organization, the Islamic Republic
of Iran with 80-year experience in the
pharmaceutical industry is considered as
a producer. While before the victory of the
Islamic Revolution, Iran supplied the need
of medicines by multinational companies
directly or indir ectly. However, after the
victory of the Islamic Revolution and
industrialization of the major part of the
pharmaceutical industry, Iran expanded
its activities in the field of producing